Extracorporeal shockwave therapy and placebo control for insomnia within diabetic neuropathy

Purpose: To allocate the influence of extracorporeal shockwaves on insomnia in comparison to placebo control in patients with a complaint of diabetic neuropathy. Methods: According to inclusion and exclusion items of the study, one hundred twenty six patients participated randomly into two equal groups, (study group) was the extracorporeal shockwave (ESW) group; (control group) was placebo receiver one. Both groups had been treated once a week for three months. Results: Outcomes established that patients in the study group had improved in foot neuropathic pain and insomnia severity; there were a significant difference between groups (p > 0.05). Conclusion: ESWT could be recommended for rehabilitation to improve the diabetic neuropathic foot pain and the severity of insomnia.